Principal Analyst, Analytics & Intelligence
Alcon
Summary
This role is part of Alcon's Analytics & Intelligence function, a team that advances data science, artificial intelligence, and machine learning to transform the eye care industry.
Job description
The Principal Analyst, Analytics & Intelligence leads advanced analytics, business intelligence, data visualization, and data science initiatives that support strategic and operational decision-making across Manufacturing, Supply Chain, Operations, Finance, Commercial, and Quality. This role applies advanced analytical techniques, including statistical analysis, predictive modeling, machine learning, and data mining, to transform complex datasets into actionable insights and scalable solutions that improve inventory management, workforce productivity, operational performance, cost effectiveness, and business outcomes.
As part of Alcon's Analytics & Intelligence organization, this position leads multiple complex technical projects from problem definition through analysis, visualization, recommendation development, and implementation support. Working with a high degree of independence, the Principal Analyst provides specialized expertise, guides cross-functional project teams, conducts research, and uses technological innovation to develop dashboards, decision-support tools, forecasts, and executive-level reporting. The role partners closely with business and functional leaders to identify performance drivers, evaluate risks and opportunities, influence decisions, and deliver measurable improvements aligned with strategic, financial, operational, quality, and regulatory objectives.
Specifics include:
- Oversee multiple technical data analysis and visualization projects.
- Ensure project goals are met through specialized expertise and technological innovation.
- Utilize data science techniques such as machine learning, predictive modeling, and statistical analysis to extract insights and create meaningful visualizations to communicate findings.
- Conduct independent research and thought leadership activities to optimize outcomes.
- Achieve goals through mainly self-directed work with potential guidance from management.
- Make critical decisions affecting project outcomes within the scope of assigned projects.
What You'll Bring to Alcon:
- Bachelor's Degree or Equivalent years of directly related experience (or high school +13 yrs; Assoc.+9 yrs; M.S.+2 yrs; PhD+0 yrs)
- The ability to fluently read, write, understand and communicate in English
- 5 Years of Relevant Experience
- Work Location: Onsite
- Travel Requirements: 0 – 10% Domestic
- Sponsorship available: No
- Relocation: No
Preferred Qualifications/Skills/Experience:
- Experience with Echelon and Tableau is a plus
Requirements
- Bachelor's Degree or equivalent years of directly related experience
- Ability to fluently read, write, understand and communicate in English
- 5 years of relevant experience
- Experience with Echelon and Tableau (preferred)
Benefits
- Health Insurance
- Life Insurance
- Retirement Planning
- Flexible Time Off
- Paid Time Off
Company overview
Alcon Inc. is the global leader in eye care, dedicated to helping people see brilliantly. Founded in 1945 as a small pharmacy in Fort Worth, Texas, the company has grown into the world's largest eye care device company with complementary businesses in Surgical and Vision Care. As a Swiss-American multinational corporation headquartered in Geneva, Switzerland with major operations in Fort Worth, Texas, Alcon operates in 60 countries and serves patients in over 140 countries. The company's Surgical segment focuses on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery, and glaucoma surgery, including implantables, consumables, and surgical equipment. The Vision Care segment comprises daily disposable, reusable, and color-enhancing contact lenses, along with a comprehensive portfolio of ocular health products for dry eye, contact lens care, and ocular allergies. With over 75 years of heritage, Alcon has a long history of industry firsts and makes substantial annual investments in research and development to meet evolving customer needs and advance patient care. The company became an independent publicly-traded entity in 2019 after spinning off from Novartis.